Insider Shareholders with Direct Ownership of Denali Therapeutics Inc. (DNLI)
This section provides a comprehensive overview of the insiders with direct ownership of Denali Therapeutics Inc. (DNLI). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Denali Therapeutics Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Flagship Ventures Fund V, L.P.
> 10% Shareholder |
8,606,249 | 0 | 8,918,749 $241 Million | 1 |
Dec 12, 2017
Added 49.11%
|
1,497,951 | 0 | 1,914,833 $51.8 Million | 1 |
Dec 12, 2017
Added 3.62%
|
|
Marc Tessier Lavigne
Director |
112,621 | 774,378 | 1,880,539 $50.9 Million | 21 |
May 31, 2024
Added 0.32%
|
Ryan J. Watts
President and CEO |
344,509 | 51,849 | 235,807 $6.38 Million | 8 |
Oct 18, 2024
Reduced 14.5%
|
Alexander O. Schuth
COFO and Secretary |
207,385 | 36,381 | 178,066 $4.82 Million | 12 |
Aug 21, 2024
Reduced 1.41%
|
Carole Ho
Chief Medical Officer |
148,340 | 35,128 | 118,810 $3.21 Million | 11 |
Aug 21, 2024
Reduced 4.74%
|
Vicki L Sato
Director |
18,243 | 43,840 | 115,156 $3.11 Million | 29 |
Sep 13, 2024
Reduced 0.88%
|
Steve E. Krognes
Director |
107,933 | 183,860 | 29,096 $787,046 | 23 |
Sep 30, 2024
Reduced 50.76%
|
Douglas G. Cole
Director |
15,529 | 0 | 26,564 $718,556 | 4 |
Jun 01, 2023
Added 13.7%
|
Peter S Klein
Director |
21,496 | 0 | 21,496 $581,466 | 5 |
May 31, 2024
Added 21.73%
|
David P Schenkein
Director |
21,496 | 75,000 | 21,496 $581,466 | 9 |
May 31, 2024
Added 21.73%
|
Jennifer E. Cook
Director |
21,496 | 1,458 | 20,038 $542,027 | 6 |
Jun 06, 2024
Reduced 6.78%
|
Nancy Thornberry
Director |
16,796 | 0 | 18,680 $505,294 | 4 |
May 31, 2024
Added 24.21%
|
Erik Harris
Director |
17,052 | 0 | 17,052 $461,256 | 3 |
May 31, 2024
Added 25.92%
|
Robert Nelsen
Director |
10,402 | 0 | 12,432 $336,285 | 4 |
Jun 02, 2021
Added 14.3%
|
Jay T Flatley
Director |
5,967 | 0 | 10,183 $275,450 | 1 |
May 31, 2024
Added 36.95%
|